The best brokers 7/2026
We did the research and clearly laid it out for you.

Zevra Therapeutics

ISIN US4884452065

 | 

WKN A2QLX7

Market cap (in EUR)
721 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 721 m
EPS, EUR 1.86
P/B ratio 4.0
P/E ratio 6.5
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 94 m
Net income, EUR 69 m
Profit margin 72.87%

What ETF is Zevra Therapeutics in?

There are 6 ETFs which contain Zevra Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Zevra Therapeutics is the L&G Pharma Breakthrough UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
Xtrackers Portfolio UCITS ETF 1C 0.00%
Equity
World
Multi-Asset Strategy
751
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.05%
Equity
United States
Health Care
Biotech
66
iShares Nasdaq US Biotechnology UCITS ETF 0.05%
Equity
United States
Health Care
Biotech
926
Xtrackers Russell 2000 UCITS ETF 1C 0.02%
Equity
United States
Small Cap
2,506
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD 0.02%
Equity
United States
Small Cap
4,824
L&G Pharma Breakthrough UCITS ETF 3.02%
Equity
World
Health Care
Innovation
19

Order fees

Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
 
Broker Rating Order fee Stock savings plans
0.99 €
4500
View offer**
0.95 €
3400
View offer*
1.00 €
2500
View offer*
0.00 €
8045
View offer*
0.00 €
7560
View offer*
Show all offers
Source: justETF Research; as of 7/2026. The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
 
Broker Rating Execution fee Account fee
0.00 €
0.00 €
View offer*
0.00 €
0.00 €
View offer*
1.50 €
1.50%
0.00 €
View offer*
0.00 €
0.00 €
View offer*
0.00 €
0.00 €
View offer*
Source: justETF Research; as of 7/2026. The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.